DE60131523D1 - Nusap, ein gen, welches für ein gewebe-spezifisches protein kodiert, verwendung als diagnosemittel und therapeutische anwendung - Google Patents

Nusap, ein gen, welches für ein gewebe-spezifisches protein kodiert, verwendung als diagnosemittel und therapeutische anwendung

Info

Publication number
DE60131523D1
DE60131523D1 DE60131523T DE60131523T DE60131523D1 DE 60131523 D1 DE60131523 D1 DE 60131523D1 DE 60131523 T DE60131523 T DE 60131523T DE 60131523 T DE60131523 T DE 60131523T DE 60131523 D1 DE60131523 D1 DE 60131523D1
Authority
DE
Germany
Prior art keywords
nusap
tissue
gene encoding
specific protein
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60131523T
Other languages
English (en)
Inventor
Roger Bouillon
Geert Carmeliet
Tim Raemaekers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Application granted granted Critical
Publication of DE60131523D1 publication Critical patent/DE60131523D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE60131523T 2000-03-16 2001-03-16 Nusap, ein gen, welches für ein gewebe-spezifisches protein kodiert, verwendung als diagnosemittel und therapeutische anwendung Expired - Lifetime DE60131523D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18974300P 2000-03-16 2000-03-16
PCT/EP2001/002971 WO2001070798A2 (en) 2000-03-16 2001-03-16 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent

Publications (1)

Publication Number Publication Date
DE60131523D1 true DE60131523D1 (de) 2008-01-03

Family

ID=22698583

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60131523T Expired - Lifetime DE60131523D1 (de) 2000-03-16 2001-03-16 Nusap, ein gen, welches für ein gewebe-spezifisches protein kodiert, verwendung als diagnosemittel und therapeutische anwendung

Country Status (6)

Country Link
EP (1) EP1263958B1 (de)
JP (1) JP2003527850A (de)
AU (1) AU8149201A (de)
CA (1) CA2401887A1 (de)
DE (1) DE60131523D1 (de)
WO (1) WO2001070798A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150971A1 (en) * 2001-02-08 2002-10-17 Johansen Jeanette Elisabeth Nucleic acids and polypeptides for controlling food intake and/or body weight
US20090125247A1 (en) * 2007-08-16 2009-05-14 Joffre Baker Gene expression markers of recurrence risk in cancer patients after chemotherapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1163524A2 (de) * 1999-03-15 2001-12-19 EOS Biotechnology, Inc. Screeningverfahren für modulatoren von darmkrebs
EP1265920B9 (de) * 2000-03-22 2007-01-24 Curagen Corporation Angiogenese-assoziierte proteine und dafür kodierende nukleinsäure

Also Published As

Publication number Publication date
EP1263958A2 (de) 2002-12-11
AU8149201A (en) 2001-10-03
EP1263958B1 (de) 2007-11-21
WO2001070798A2 (en) 2001-09-27
CA2401887A1 (en) 2001-09-27
WO2001070798A3 (en) 2002-07-25
JP2003527850A (ja) 2003-09-24

Similar Documents

Publication Publication Date Title
AU2002344208A8 (en) Molecules for diagnostics and therapeutics
GB2383962B (en) Catalytic composition and use therefor
DE60227129D1 (de) Partikel für Elektrophorese, Verfahren zu ihrer Herstellung und diese Partikel verwendendes Display
DE60139284D1 (de) Behandlungsmittel für colorierte Haare
DE60221236D1 (de) Gewebte vorform für eine konstruktionsverbindung
PL366142A1 (en) Hydroprocessing catalyst and use thereof
DE60223857D1 (de) Verbindung für Bewehrungsstäbe und Verbindungsverfahren
DE60200118D1 (de) Bewehrungsstabverbindung und Verbindungsverfahren
DE69936514D1 (de) Heliomycin-kodierendes gen und seine verwendung
DE60200892D1 (de) Bewehrungsstabverbindung und Verbindungsverfahren
EP1414847A4 (de) Isolierte sezernierte humanproteine, sezernierte humanproteine codierende nukleinsäuremoleküle sowie verwendungen davon
EP1210416A4 (de) Gene, welche für proteine zur diagnostischen, vorbeugenden und therapeutischen verwendung kodieren
DE69521416T2 (de) Glasmaterial, ersatzmaterial für lebendes gewebe und zahnverstärkendes material
DE60131523D1 (de) Nusap, ein gen, welches für ein gewebe-spezifisches protein kodiert, verwendung als diagnosemittel und therapeutische anwendung
ATE412673T1 (de) Chimäres gapc protein aus streptococcus und dessen verwendung zur impfung und diagnostik
NO20005919D0 (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse
EP1414844A4 (de) Isolierte humane sezernierte proteine, nukleinsäuremoleküle, die humane sezernierte proteine codieren, und deren verwendungen
DE60222350D1 (de) Kernstück für Gummiraupenkette und Gummiraupenkette
DE60220532D1 (de) Zusammensetzung zur verwendung als selbstblockierendes mittel und dieses verwendendes selbstblockierendes glied
EP1379629A4 (de) Isolierte menschliche arzneistoffmetabolisierende proteine, menschliche arzneistoffmetabolisierende proteine codierende nukleinsäuremoleküle sowie verwendungen davon
DE60041458D1 (de) Harzzusammensetzung für toner, und toner
DE60107858D1 (de) Nukleotid sequenzen kodierend für das lysr3 gen
EP1414422A4 (de) Isolierte humane sezernierte proteine, nukleinsäuremoleküle, die humane sezernierte proteine codieren, und deren verwendung
NO20024029D0 (no) Nytt protein og gen som koder for proteinet
AU2769101A (en) Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses

Legal Events

Date Code Title Description
8332 No legal effect for de